Profile data is unavailable for this security.
About the company
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
- Revenue in USD (TTM)566.35m
- Net income in USD90.47m
- Incorporated2018
- Employees728.00
- LocationTransmedics Group Inc200 Minuteman RoadANDOVER 01810United StatesUSA
- Phone+1 (978) 552-0900
- Websitehttps://www.transmedics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp | 1.32bn | 175.44m | 2.68bn | 3.02k | 15.87 | 2.97 | 9.32 | 2.04 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Integer Holdings Corp | 1.83bn | 87.20m | 3.01bn | 11.00k | 35.84 | 1.72 | 14.25 | 1.64 | 2.40 | 2.39 | 51.76 | 49.83 | 0.5578 | 5.04 | 4.83 | 166,461.30 | 2.66 | 3.28 | 2.84 | 3.54 | 27.15 | 26.70 | 4.76 | 6.38 | 2.45 | 5.23 | 0.4112 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| ICU Medical Inc | 2.32bn | -7.36m | 3.58bn | 15.00k | -- | 1.68 | 18.25 | 1.54 | -0.3109 | -0.3109 | 94.30 | 86.17 | 0.552 | 2.24 | 12.70 | 154,690.90 | -0.206 | -0.2042 | -0.2351 | -0.2306 | 36.47 | 33.82 | -0.3731 | -0.3326 | 1.19 | 1.62 | 0.3829 | -- | 5.44 | 13.47 | -296.86 | -- | -3.18 | -- |
| LivaNova PLC | 1.35bn | -217.49m | 3.59bn | 2.90k | -- | 3.10 | -- | 2.66 | -4.01 | -4.01 | 24.64 | 21.19 | 0.5311 | 2.58 | 6.60 | 465,159.30 | -8.56 | -4.14 | -11.07 | -5.03 | 68.50 | 67.61 | -16.12 | -9.04 | 1.12 | 10.22 | 0.273 | -- | 8.66 | 2.94 | 260.39 | -- | 10.98 | -- |
| TransMedics Group Inc | 566.35m | 90.47m | 4.44bn | 728.00 | 54.54 | 12.48 | 38.22 | 7.83 | 2.38 | 2.41 | 14.48 | 10.40 | 0.6541 | 4.65 | 6.63 | 777,958.80 | 10.45 | -5.73 | 11.37 | -6.28 | 60.28 | 62.37 | 15.97 | -11.86 | 7.13 | 31.19 | 0.5903 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Teleflex Inc | 3.19bn | -327.85m | 4.59bn | 14.10k | -- | 1.20 | -- | 1.44 | -7.35 | -7.36 | 70.55 | 86.48 | 0.4154 | 2.05 | 6.00 | 226,240.30 | -4.27 | 4.58 | -4.69 | 5.01 | 53.67 | 54.77 | -10.28 | 11.38 | 1.53 | 6.78 | 0.4114 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Lantheus Holdings Inc | 1.53bn | 167.68m | 4.60bn | 808.00 | 29.14 | 4.11 | 19.81 | 3.02 | 2.38 | 2.38 | 21.90 | 16.88 | 0.7055 | 8.67 | 4.48 | 1,888,531.00 | 7.75 | 9.87 | 10.50 | 11.33 | 62.23 | 60.44 | 10.99 | 12.86 | 2.49 | -- | 0.337 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| iRhythm Holdings, Inc | 702.57m | -51.46m | 4.65bn | 2.00k | -- | 38.10 | -- | 6.61 | -1.62 | -1.62 | 22.11 | 3.78 | 0.7377 | 12.04 | 9.15 | 351,286.50 | -5.40 | -20.12 | -6.21 | -24.37 | 70.35 | 68.61 | -7.32 | -23.90 | 4.50 | -- | 0.8418 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.75bn | 12.00k | 105.36 | 1.53 | 29.13 | 1.75 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Merit Medical Systems Inc | 1.48bn | 118.43m | 4.84bn | 7.40k | 41.80 | 3.17 | 19.79 | 3.28 | 1.95 | 1.95 | 24.37 | 25.80 | 0.5898 | 2.39 | 7.38 | 199,611.90 | 4.73 | 3.49 | 5.17 | 3.93 | 48.47 | 45.37 | 8.02 | 5.65 | 2.86 | 14.41 | 0.324 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| Stevanato Group SpA | 1.39bn | 166.85m | 4.85bn | 5.52k | 26.19 | 2.56 | 18.22 | 3.49 | 0.6113 | 0.6113 | 5.09 | 6.25 | 0.5058 | 2.95 | 2.65 | 251,569.00 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Bruker Corp | 3.44bn | -22.50m | 5.55bn | 11.40k | -- | 2.24 | 27.86 | 1.61 | -0.1487 | -0.1487 | 22.61 | 16.28 | 0.5705 | 1.67 | 5.71 | -- | -0.1212 | 5.07 | -0.155 | 6.76 | 46.70 | 49.41 | -0.2124 | 7.56 | 0.8739 | 7.79 | 0.4268 | 13.13 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.82bn | -- | -- | 12.16 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.27bn | 13.50k | -- | 1.13 | -- | 0.9577 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.61 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Glaukos Corp | 469.82m | -87.61m | 6.29bn | 995.00 | -- | 8.16 | -- | 13.38 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
Data as of Feb 13 2026. Currency figures normalised to Transmedics Group Inc's reporting currency: US Dollar USD
54.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 4.81m | 14.11% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 4.60m | 13.48% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.32m | 9.75% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.28m | 3.74% |
| Nomura Investment Management Business Trustas of 30 Sep 2025 | 906.27k | 2.66% |
| Geode Capital Management LLCas of 31 Dec 2025 | 816.47k | 2.40% |
| Driehaus Capital Management LLCas of 30 Sep 2025 | 738.16k | 2.17% |
| Hood River Capital Management LLCas of 30 Sep 2025 | 678.44k | 1.99% |
| Goldman Sachs Asset Management LPas of 31 Dec 2025 | 659.86k | 1.94% |
| Two Sigma Investments LPas of 30 Sep 2025 | 635.39k | 1.86% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
